Klaas Vandenbroucke

Orally administered L. lactis secreting an anti-TNF Nanobody demonstrate efficacy in chronic colitis

Klaas Vandenbroucke, Hans de Haard, Els Beirnaert et al. · Mucosal Immunology · 2009 · 279 citations

Inflammation, Nanomedicine, Anti-inflammatory +10

Active delivery of trefoil factors by genetically modified Lactococcus lactis prevents and heals acute colitis in mice

Klaas Vandenbroucke, Wolfgang Hans, Jacques Van Huysse et al. · Gastroenterology · 2004 · 273 citations · Full text

Inflammation, Active Delivery, Mucosal Immunology +11

AG013, a mouth rinse formulation of Lactococcus lactis secreting human Trefoil Factor 1, provides a safe and efficacious therapeutic tool for treating oral mucositis

Silvia Caluwaerts, Klaas Vandenbroucke, Lothar Steidler et al. · Oral Oncology · 2010 · 128 citations

Medical Microbiology, Probiotic, Antimicrobial Susceptibility +9

Intracellular Accumulation of Trehalose Protects <i>Lactococcus lactis</i> from Freeze-Drying Damage and Bile Toxicity and Increases Gastric Acid Resistance

Sofie Termont, Klaas Vandenbroucke, D. Iserentant et al. · Applied and Environmental Microbiology · 2006 · 57 citations · Full text

Expression of galectins‐1, ‐3 and ‐4 varies with strain and type of experimental colitis in mice

Anne Mathieu, Christine Decaestecker, Liesbeth Ferdinande et al. · International Journal of Experimental Pathology · 2008 · 12 citations · Full text

Chronic Inflammatory Diseases, Microbial Pathogens, Immunology +18